Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Chemomab Therapeutics Ltd.

Headquarters: Tel Aviv, Israel
Year Founded: 2011
Status: Public
Industry Sector: HealthTechnology
CEO: Adi Mor, PhD
Number Of Employees: N/A
Enterprise Value: $15,362,806
PE Ratio: -1.63
Exchange/Ticker 1: NASDAQ:CMMB
Exchange/Ticker 2: N/A
Latest Market Cap: $28,284,900

BioCentury | Jun 12, 2024
Management Tracks

Former Fusion CFO Crowley joins Centessa

Weinhoff becomes CBO. Plus: QurAlis pads C-suite and updates from PepGen, C4 and more
BioCentury | Dec 7, 2021
Management Tracks

Biohaven names Coric chair, Buten CFO

Plus: Mutamba joins Arrakis as CBO and updates from Goldfinch, Kymera, AnHeart and more
BioCentury | Sep 3, 2021
Management Tracks

Civetta picks Roberts as CEO

Plus, management moves at Crinetics, OraSure, Silence, Avacta, Oncternal and more
Items per page:
1 - 3 of 3
Help Center
Username
Request a Demo
Request Training
Ask a Question